Related Experiment Videos
Searching for a general anaesthesia protocol for rapid detoxification from opioids.
P Lorenzi1, M Marsili, S Boncinelli
1Department of Clinical Pathophysiology, University of Florence, Careggi General Hospital, Italy.
European Journal of Anaesthesiology
|December 3, 1999
Summary
Ultra-rapid opioid detoxification uses opioid antagonists like naloxone under general anesthesia to speed up withdrawal. This study found the anesthesia protocol safe, with mild withdrawal signs and stable patient vitals.
Area of Science:
- Anesthesiology
- Pharmacology
- Addiction Medicine
Background:
- Ultra-rapid opioid detoxification aims to shorten withdrawal by using opioid antagonists (naloxone, naltrexone) under sedation or anesthesia.
- This method faces controversy due to potential risks associated with sedation/anesthesia during acute withdrawal.
Purpose of the Study:
- To evaluate the safety and efficacy of a specific anesthesia protocol for ultra-rapid opioid detoxification.
- To assess hemodynamic and respiratory stability during naloxone-induced withdrawal under general anesthesia.
Main Methods:
- 12 opiate-addicted patients underwent ultra-rapid opioid detoxification.
- Naloxone (4 mg) was infused over 5 hours during general anesthesia (midazolam, propofol, atracurium) with controlled ventilation.
- Invasive cardiovascular and respiratory monitoring was employed, with withdrawal signs assessed using a graduated scale.
Main Results:
- The anesthesia protocol maintained patient stability, evidenced by minimal changes in hemodynamic values.
- Patients exhibited only mild signs of opioid withdrawal during the procedure.
- Anesthesia was sustained for one hour post-naloxone infusion without adverse events.
Conclusions:
- The described general anesthesia protocol is a valid and safe method for facilitating ultra-rapid opioid detoxification.
- This approach effectively manages acute withdrawal symptoms while ensuring patient comfort and safety.